Benchmark raised the firm’s price target on RCM Technologies (RCMT) to $36 from $32 and keeps a Buy rating on the shares following a Q4 beat driven by stronger operating leverage on inline revenue. The firm retains a cautious view on a rebound in Life Sciences in FY26, but sees potential upside in Engineering Services, the analyst tells investors in a post-earnings note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RCMT:
